Stepan (SCL) Q1 2026 Earnings Call Transcript
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 28 2026
0mins
Should l Buy SCL?
Source: NASDAQ.COM
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SCL?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SCL
About SCL
Stepan Company produces and sells intermediate chemicals that are used in a variety of applications. Its segment includes Surfactants, Polymers and Specialty Products. Surfactants are used in various consumer and industrial cleaning and disinfection products, such as detergents for washing clothes, dishes, floors and walls. Its other applications include fabric softeners, germicidal quaternary compounds, disinfectants, lubricating ingredients, emulsifiers for spreading agricultural products and industrial applications, such as latex systems, plastics and composites. Polymers include polyurethane polyols, polyester resins and phthalic anhydride. Polyurethane polyols are used in the manufacture of rigid foam for thermal insulation in the construction industry and are also a base raw material for coatings, adhesives, sealants and elastomers. Specialty Products include flavors, emulsifiers and solubilizers used in food, flavoring, nutritional supplements and pharmaceutical applications.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Dividend Increase: Stepan Company has declared a quarterly dividend of $0.395 per share, representing a 2.6% increase from the previous $0.385, indicating the company's ongoing commitment to stable cash flow and shareholder returns, which is likely to boost investor confidence.
- Yield Metrics: The forward yield of this dividend stands at 3.0%, providing investors with a relatively attractive return rate, reflecting the company's financial health in the current economic environment.
- Record Dates: The dividend will be payable on June 15, with a record date of June 1 and an ex-dividend date also set for June 1, offering investors a clear timeline for their investment decisions.
- Cost Savings Initiative: Stepan is implementing a $100 million cost savings plan, which is expected to drive EBITDA growth in 2026 amid restructuring efforts, demonstrating the company's strategic commitment to optimizing operations and enhancing profitability.
See More
- Performance Overview: Stepan Company's Q1 Non-GAAP EPS of $0.45 beats expectations by $0.06, indicating some resilience in profitability despite market pressures.
- Revenue Performance: The revenue for Q1 stands at $604.51 million, reflecting a 1.9% year-over-year increase, yet it misses expectations by $7.74 million, highlighting challenges in market demand.
- Adjusted EBITDA Decline: Adjusted EBITDA is reported at $49.6 million, down 14% year-over-year, suggesting pressures on cost control and profitability that may impact future investment decisions.
- Cash Flow Situation: Cash from operations was $16.9 million, while free cash flow was negative $14.0 million, indicating challenges in cash management that could affect the company's financial flexibility moving forward.
See More
- Significant Stock Surge: Albemarle (ALB) shares soared 16.3% in the last trading session to close at $215.62, with trading volume significantly exceeding normal levels, indicating strong market confidence in its future performance.
- Lithium Price Rebound: The global rebound in lithium prices, driven by robust demand and tight supply, particularly from electric vehicles and energy storage systems, is expected to further enhance ALB's performance, creating a positive feedback loop.
- Strong Earnings Expectations: Albemarle is projected to report quarterly earnings of $1.00 per share, reflecting a staggering year-over-year increase of 655.6%, with revenues expected to reach $1.29 billion, up 19.7% from the previous year, showcasing the company's strong profitability.
- Upward Earnings Revisions: Over the past 30 days, the consensus EPS estimate for ALB has been revised 2.7% higher, and such positive earnings estimate revisions are typically correlated with stock price appreciation, prompting investors to monitor its future performance closely.
See More










